{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T10:14:09Z","timestamp":1780740849879,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11655-025-4224-z","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T07:32:48Z","timestamp":1748244768000},"page":"1069-1077","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Triptolide Ameliorates Collagen-Induced Arthritis and Bleomycin-Induced Pulmonary Fibrosis in Rats by Suppressing IGF1-Mediated Epithelial Mesenchymal Transition"],"prefix":"10.1007","volume":"31","author":[{"given":"Pei-pei","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-qi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-cheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-yu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"4224_CR1","doi-asserted-by":"publisher","first-page":"102776","DOI":"10.1016\/j.autrev.2021.102776","volume":"20","author":"FA Figus","year":"2021","unstructured":"Figus FA, Piga M, Azzolin I, McConnell R, Iagnocco A. Rheumatoid arthritis: extra-articular manifestations and comorbidities. Autoimmun Rev 2021;20:102776.","journal-title":"Autoimmun Rev"},{"key":"4224_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/BOR.0000000000000703","volume":"32","author":"BR England","year":"2020","unstructured":"England BR, Hershberger D. Management issues in rheumatoid arthritis-associated interstitial lung disease. Curr Opin Rheumatol 2020;32:255\u2013263.","journal-title":"Curr Opin Rheumatol"},{"key":"4224_CR3","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1093\/rheumatology\/keaa608","volume":"60","author":"S Izuka","year":"2021","unstructured":"Izuka S, Yamashita H, Iba A, Takahashi Y, Kaneko H. Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: clinical features and prognosis. Rheumatology (Oxford) 2021;60:2348\u20132354.","journal-title":"Rheumatology (Oxford)"},{"key":"4224_CR4","doi-asserted-by":"publisher","first-page":"103056","DOI":"10.1016\/j.autrev.2022.103056","volume":"21","author":"M Akiyama","year":"2022","unstructured":"Akiyama M, Kaneko Y. Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease. Autoimmun Rev 2022;21:103056.","journal-title":"Autoimmun Rev"},{"key":"4224_CR5","first-page":"14","volume":"15","author":"M Liang","year":"2022","unstructured":"Liang M, Matteson EL, Abril A, Distler JHW. The role of antifibrotics in the treatment of rheumatoid arthritis-associated interstitial lung disease. Ther Adv Musculoskelet Dis 2022;15;14.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"4224_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/qjmed\/hcac068","volume":"115","author":"S Hanai","year":"2022","unstructured":"Hanai S, Kobayashi Y, Ito R, Maejima Y, Nakagomi D. Methotrexate-associated pneumonitis. QJM 2022;115:305\u2013307.","journal-title":"QJM"},{"key":"4224_CR7","first-page":"501","volume":"18","author":"J Narv\u00e1ez","year":"2022","unstructured":"Narv\u00e1ez J, D\u00edaz Del Campo Fontecha P, Brito Garc\u00eda N, Bonilla G, Aburto M, Castellv\u00ed I, et al. SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment. Reumatol Clin (Engl Ed) 2022;18:501\u2013512.","journal-title":"Part 2: Treatment. Reumatol Clin (Engl Ed)"},{"key":"4224_CR8","doi-asserted-by":"publisher","first-page":"e28501","DOI":"10.1097\/MD.0000000000028501","volume":"101","author":"KH Yu","year":"2022","unstructured":"Yu KH, Chen HH, Cheng TT, Jan YJ, Weng MY, Lin YJ, et al. Consensus recommendations on managing the selected comorbidities including cardiovascular disease, osteoporosis, and interstitial lung disease in rheumatoid arthritis. Medicine (Baltimore) 2022;101:e28501.","journal-title":"Medicine (Baltimore)"},{"key":"4224_CR9","doi-asserted-by":"publisher","first-page":"152312","DOI":"10.1016\/j.semarthrit.2023.152312","volume":"64","author":"PA Juge","year":"2024","unstructured":"Juge PA, Hayashi K, McDermott GC, Vanni KMM, Kowalski E, Qian G, et al. Effectiveness and tolerability of antifibrotics in rheumatoid arthritis-associated interstitial lung disease. Semin Arthritis Rheum 2024;64:152312.","journal-title":"Semin Arthritis Rheum"},{"key":"4224_CR10","doi-asserted-by":"publisher","first-page":"1282610","DOI":"10.3389\/fphar.2023.1282610","volume":"14","author":"Y Shan","year":"2023","unstructured":"Shan Y, Zhao J, Wei K, Jiang P, Xu L, Chang C, et al. A comprehensive review of Tripterygium wilfordii hook. F. in the treatment of rheumatic and autoimmune diseases: bioactive compounds, mechanisms of action, and future directions. Front Pharmacol 2023;14:1282610.","journal-title":"Front Pharmacol"},{"key":"4224_CR11","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/ijms19020376","volume":"19","author":"D Fan","year":"2018","unstructured":"Fan D, Guo Q, Shen J, Zheng K, Lu C, Zhang G, et al. The effect of triptolide in rheumatoid arthritis: from basic research towards clinical translation. Int J Mol Sci 2018;19:376.","journal-title":"Int J Mol Sci"},{"key":"4224_CR12","doi-asserted-by":"publisher","first-page":"116418","DOI":"10.1016\/j.biopha.2024.116418","volume":"173","author":"X Jian","year":"2024","unstructured":"Jian X, Shi C, Luo W, Zhou L, Jiang L, Liu K. Therapeutic effects and molecular mechanisms of quercetin in gynecological disorders. Biomed Pharmacother 2024;173:116418.","journal-title":"Biomed Pharmacother"},{"key":"4224_CR13","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3390\/molecules27051481","volume":"27","author":"M Hasan","year":"2022","unstructured":"Hasan M, Paul NC, Paul SK, Saikat ASM, Akter H, Mandal M, et al. Natural product-based potential therapeutic interventions of pulmonary fibrosis. Molecules 2022;27:1481.","journal-title":"Molecules"},{"key":"4224_CR14","doi-asserted-by":"publisher","first-page":"115394","DOI":"10.1016\/j.biopha.2023.115394","volume":"166","author":"W Lin","year":"2023","unstructured":"Lin W, Song Y, Li T, Yan J, Zhang R, Han L, et al. Triptolide attenuates pulmonary fibrosis by inhibiting fibrotic extracellular matrix remodeling mediated by MMPs\/LOX\/ integrin. Biomed Pharmacother 2023;166:115394.","journal-title":"Biomed Pharmacother"},{"key":"4224_CR15","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"4224_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010;26:139\u2013140.","journal-title":"Bioinformatics"},{"key":"4224_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/1471-2105-15-293","volume":"15","author":"P Bardou","year":"2014","unstructured":"Bardou P, Mariette J, Escudi\u00e9 F, Djemiel C, Klopp C. Jvenn: an interactive Venn diagram viewer. BMC Bioinformatics 2014;15:293.","journal-title":"BMC Bioinformatics"},{"key":"4224_CR18","doi-asserted-by":"publisher","first-page":"e0294236","DOI":"10.1371\/journal.pone.0294236","volume":"18","author":"D Tang","year":"2023","unstructured":"Tang D, Chen M, Huang X, Zhang G, Zeng L, Zhang G, et al. SRplot: a free online platform for data visualization and graphing. PLoS One 2023;18:e0294236.","journal-title":"PLoS One"},{"key":"4224_CR19","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Rese 2021;49:D605\u2013D612.","journal-title":"Nucleic Acids Rese"},{"key":"4224_CR20","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003;13:2498\u20132504.","journal-title":"Genome Res"},{"key":"4224_CR21","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13075-019-2047-z","volume":"21","author":"AL Mausset-Bonnefont","year":"2019","unstructured":"Mausset-Bonnefont AL, Cren M, Vicente R, Quentin J, Jorgensen C, Apparailly F, et al. Arthritis sensory and motor scale: predicting functional deficits from the clinical score in collagen-induced arthritis. Arthritis Res Ther 2019;21:264.","journal-title":"Arthritis Res Ther"},{"key":"4224_CR22","doi-asserted-by":"publisher","first-page":"2100864","DOI":"10.1183\/13993003.00864-2021","volume":"59","author":"S Song","year":"2022","unstructured":"Song S, Fu Z, Guan R, Zhao J, Yang P, Li Y, et al. Intracellular hydroxyproline imprinting following resolution of bleomycin-induced pulmonary fibrosis. Eur Respir J 2022;59:2100864.","journal-title":"Eur Respir J"},{"key":"4224_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s42358-023-00325-z","volume":"63","author":"H Liu","year":"2023","unstructured":"Liu H, Yang Y, Zhang J, Li X. Baricitinib improves pulmonary fibrosis in mice with rheumatoid arthritis-associated interstitial lung disease by inhibiting the JAK2\/STAT3 signaling pathway. Adv Rheumatol (Engl Ed) 2023;63:45.","journal-title":"Adv Rheumatol (Engl Ed)"},{"key":"4224_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3389\/fphar.2017.00230","volume":"8","author":"Q Guo","year":"2017","unstructured":"Guo Q, Zheng K, Fan D, Zhao Y, Li L, Bian Y, et al. Wu-Tou Decoction in rheumatoid arthritis: integrating network pharmacology and in vivo pharmacological evaluation. Front Pharmacol 2017;8:230.","journal-title":"Front Pharmacol"},{"key":"4224_CR25","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.2147\/DDDT.S361748","volume":"16","author":"J Liu","year":"2022","unstructured":"Liu J, Fan G, Tao N, Feng F, Meng C, Sun T. Ginsenoside Rb1 alleviates bleomycin-induced pulmonary inflammation and fibrosis by suppressing central nucleotide-binding oligomerization-, leucine-rich repeat-, and pyrin domains-containing protein three inflammasome activation and the NF-\u03baB pathway. Drug Des Devel Ther 2022;16:1793\u20131809.","journal-title":"Drug Des Devel Ther"},{"key":"4224_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s41927-024-00403-9","volume":"8","author":"AM Boudal","year":"2024","unstructured":"Boudal AM, Alsaigh RG, Alrajhi NN, Idrees MM, Omair MA, Al Rayes HM, et al. Exploring rheumatoid arthritis associated interstitial lung disease\u2014a retrospective study from two Saudi tertiary care centers. BMC Rheumatol 2024;8:32.","journal-title":"BMC Rheumatol"},{"key":"4224_CR27","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.2147\/DDDT.S467929","volume":"18","author":"M Jiang","year":"2024","unstructured":"Jiang M, Xie Y, Wang P, Du M, Wang Y, Yan S. Research progress of triptolide against fibrosis. Drug Des Develop Ther 2024;18:3255\u20133266.","journal-title":"Drug Des Develop Ther"},{"key":"4224_CR28","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1183\/09031936.00092309","volume":"356","author":"EJ Kim","year":"2010","unstructured":"Kim EJ, Elicker BM, Maldonado F, Webb WR, Ryu JH, Van Uden JH, et al. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 2010;356:1322\u20131328.","journal-title":"Eur Respir J"},{"key":"4224_CR29","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41420-022-01291-z","volume":"8","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Liang J, Cao N, Gao J, Song L, Tang X. Coal dust nanoparticles induced pulmonary fibrosis by promoting inflammation and epithelial-mesenchymal transition via the NF-\u03baB\/NLRP3 pathway driven by IGF1\/ROS-mediated AKT\/GSK3\u03b2 signals. Cell Death Discov 2022;8:500.","journal-title":"Cell Death Discov"},{"key":"4224_CR30","first-page":"6057589","volume":"2018","author":"Z Wang","year":"2018","unstructured":"Wang Z, Li W, Guo Q, Wang Y, Ma L, Zhang X. Insulinlike growth factor-1 signaling in lung development and inflammatory lung diseases. Biomed Res Int 2018;2018:6057589.","journal-title":"Biomed Res Int"},{"key":"4224_CR31","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1080\/07853890.2022.2034931","volume":"54","author":"W Zhu","year":"2022","unstructured":"Zhu W, Li Y, Zhao J, Wang Y, Li Y, Wang Y. The mechanism of triptolide in the treatment of connective tissue disease-related interstitial lung disease based on network pharmacology and molecular docking. Ann Med 2022;54:541\u2013552.","journal-title":"Ann Med"},{"key":"4224_CR32","doi-asserted-by":"publisher","first-page":"2000337","DOI":"10.1183\/13993003.00337-2020","volume":"572","author":"PA Juge","year":"2021","unstructured":"Juge PA, Lee JS, Lau J, Kawano-Dourado L, Rojas Serrano J, Sebastiani M, et al. Methotrexate and rheumatoid arthritis associated interstitial lung disease. Eur Respir J 2021;572:2000337.","journal-title":"Eur Respir J"},{"key":"4224_CR33","first-page":"e72486","volume":"16","author":"SJ Patil","year":"2024","unstructured":"Patil SJ, Thorat VM, Koparde AA, Bhinge SD, Chavan DD, Bhosale RR. Unlocking the future: new biologic therapies for rheumatoid arthritis. Cureus 2024;16:e72486.","journal-title":"Cureus"},{"key":"4224_CR34","doi-asserted-by":"publisher","first-page":"182","DOI":"10.63032\/POPM9413","volume":"3","author":"AC Duarte","year":"2024","unstructured":"Duarte AC, Marques Gomes C, Correia M, Mendes B, Mazeda C, Guimar\u00e3es F, et al. Antifibrotics in rheumatoid arthritis-associated interstitial lung disease\u2014real-world data from a nationwide cohor. ARP Rheumatol 2024;3:182\u2013188.","journal-title":"ARP Rheumatol"},{"key":"4224_CR35","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3899\/jrheum.2024-0976","volume":"52","author":"M Sebastiani","year":"2025","unstructured":"Sebastiani M, Lepri G, Iannone C, Cassione EB, Guggino G, Lo Monaco A, et al. Nintedanib in rheumatoid arthritis-related interstitial lung disease: real-world safety profile and risk of side effects and discontinuation. J Rheumatol 2025;52:420\u2013425.","journal-title":"J Rheumatol"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-025-4224-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-025-4224-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-025-4224-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T08:13:49Z","timestamp":1764836029000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-025-4224-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["4224"],"URL":"https:\/\/doi.org\/10.1007\/s11655-025-4224-z","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"26 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Author LYU Cheng is a younger member of the editorial Board for CJIM. The paper was handled by the other Editor and has undergone rigorous peer review process. Author LYU Cheng was not involved in the journal\u2019s review of, or decisions related to, this manuscript. All authors report there are no conflicts of interest related to the present article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}